Similar articles

• Intraventricular administration of recombinant tissue plasminogen activator for intraventricular hemorrhage in the newborn.

  Akisu M, Yalaz M, Arslanoglu S, Kultursay N. Akisu M, et al. Neurosurg Rev. 2003 Oct;26(4):266-8. doi: 10.1007/s10143-003-0282-9. Epub 2003 Jun 11. Neurosurg Rev. 2003. PMID: 12802693
• Fibrinolytic agents in the management of posthemorrhagic hydrocephalus in preterm infants: the evidence.

  Haines SJ, Lapointe M. Haines SJ, et al. Childs Nerv Syst. 1999 May;15(5):226-34. doi: 10.1007/s003810050378. Childs Nerv Syst. 1999. PMID: 10392493 Review.
• [Treatment of posthemorrhagic hydrocephalus with intraventricular administration of recombinant plasminogen activator (rt-PA) and dexamethasone--possible prevention of permanent shunt implantation?].

  Erler T, Kläber HG. Erler T, et al. Z Geburtshilfe Neonatol. 2001 Jan-Feb;205(1):27-32. doi: 10.1055/s-2001-14554. Z Geburtshilfe Neonatol. 2001. PMID: 11253732 German.
• Phase I study of intraventricular recombinant tissue plasminogen activator for treatment of posthaemorrhagic hydrocephalus.

  Whitelaw A, Saliba E, Fellman V, Mowinckel MC, Acolet D, Marlow N. Whitelaw A, et al. Arch Dis Child Fetal Neonatal Ed. 1996 Jul;75(1):F20-6. doi: 10.1136/fn.75.1.f20. Arch Dis Child Fetal Neonatal Ed. 1996. PMID: 8795351 Free PMC article. Clinical Trial.
• Intraventricular streptokinase infusion in acute post-haemorrhagic hydrocephalus.

  Luciano R, Tortorolo L, Chiaretti A, Piastra M, Velardi F, Polidori G. Luciano R, et al. Intensive Care Med. 1998 May;24(5):526-9. doi: 10.1007/s001340050606. Intensive Care Med. 1998. PMID: 9660271 Review.